BiotechTube

PF-04383119 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
51
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cystitis, Interstitial

Conditions

Cystitis, Interstitial

Trial Timeline

Mar 17, 2008 → Apr 15, 2009

NCT ID
NCT00601484

About PF-04383119 + Placebo

PF-04383119 + Placebo is a phase 2 stage product being developed by Pfizer for Cystitis, Interstitial. The current trial status is completed. This product is registered under clinical trial identifier NCT00601484. Target conditions include Cystitis, Interstitial.

Hype Score Breakdown

Clinical
17
Activity
12
Company
9
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00601484Phase 2Completed

Competing Products

19 competing products in Cystitis, Interstitial

See all competitors
ProductCompanyStageHype Score
Ferumoxytol + GadobutrolLipella PharmaceuticalsPhase 1
25
LP-10Lipella PharmaceuticalsPhase 2
44
LP-08 80mg + Normal saline + LP-08 20mgLipella PharmaceuticalsPhase 2
44
ASP3652 + PlaceboAstellas PharmaPhase 2
52
Mirabegron + PlaceboAstellas PharmaPhase 3
77
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Placebo + JNJ-42160443Johnson & JohnsonPhase 2
52
Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mgJohnson & JohnsonApproved
85
BOTOX + Placebo for BOTOXAbbViePhase 2
52
RocuroniumMerckApproved
85
CidofovirGilead SciencesPre-clinical
22
PD 0299685 at 15mg BID + PD 0299685 at 30mg BID + placebo for PD 0299685PfizerPhase 2
51
Tanezumab + Tanezumab + Tanezumab + TanezumabPfizerPhase 2
51
ERB-041PfizerPre-clinical
22
Certolizumab pegol + PlaceboUCBPhase 3
74
moxifloxacinBayerPhase 3
74
Cipro (Ciprofloxacin, BAYQ3939)BayerPre-clinical
20
IW-3300 rectal foam + PlaceboIronwood PharmaceuticalsPhase 2
44
MN-001 BID + MN-001 + PlaceboMediciNovaPhase 2
44

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84